a year ago

Oxford Endovascular Secures £8M to Advance Brain Aneurysm Treatment Device

  • Oxford Endovascular, a UK-based medtech startup, has raised £8 million in Series A funding to advance its brain aneurysm treatment technology

  • The company's device, OXIFLOW, diverts blood flow away from intracranial aneurysms at risk of rupture

  • The funding will be used for further product development and clinical trials

  • OXIFLOW is designed to be more accurate and reliable than conventional flow-diverters, reducing the risk of complications associated with current treatments.

      • ProblemHealthcare

      "Brain aneurysms are a serious medical condition that can lead to life-threatening bleeding in the brain. Existing treatments for aneurysms are not always effective and can have serious side effects. "

      Solution

      "OXIFLOW is a flow-diverter stent that is designed to divert blood flow away from aneurysms, reducing the risk of rupture. The device is made from a special metal alloy that allows it to be positioned and opened more accurately than existing devices. "

      Covered on